Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis

Acta Oto-Laryngologica

Volumn 123, Issue 3, 2003, Pages 377-382

  Huisman, Margriet A ^a   De Heer, Emile ^a   Grote, Jan J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Active caspase 3; Apoptosis; Cholesteatoma; Immunohistochemistry; Ki 67; P21; P53; Terminal deoxynucleotide transferase mediated dUTP nick end labeling

Indexed keywords

CASPASE 3; DNA FRAGMENT; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MITOSIS INHIBITION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0242584430     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310001376     Document Type: Article

References (21)

1. Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998; 19: 7-19.
2. Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H. Comparative analysis of the proliferative capacity of cholesteatomas. Acta Otorrinolaringol Esp 2000; 51: 299-307.
3. Schuler M, Green DR. Mechanism of p53-dependent apoptosis. Biochem Soc Trans 2001; 29: 684-8.
4. Hengarter MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
5. Earnshaw W, Martins L, Kaufmann SH. Mammalian caspases: structure, activation, substrates and functioning during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
6. Bargonetti J, Manfredi JJ. Multiple roles of the tumour suppressor p53. Curr Opin Oncol 2002; 14: 86-91.
7. Vogt Sionov R, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999; 18: 6145-57.
8. Motamed M, Powe D, Jones L, Kendall C, Banerjee AR. Are p53 and MIB-1 overexpressed in cholesteatoma? Clin Otolaryngol 2000; 25: 575.
9. Choufani G, Mahillon V, Decaestecker C, et al. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999; 109: 1825-31.
10. Ergun S, Carlsöö B, Zheng X. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol 1999; 24: 280-5.
11. Koyima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998; 124: 261-4.
12. Hazelbag HM, v.d. Broek LJCM, van Dorst EBL, Offerhaus JA, Fleuren GJ, Hogendoorn PCW. Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic treatments. J Histochem Cytochem 1995; 43: 429-37.
13. Wrone-Smith T, Bergstrom J, Quevedo ME, Reddy V, Gutierrez-Steil C, Nickoloff BJ. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci 1999; 19: 53-67.
14. Negoescu A, Lorimier P, Labat-Moleur F, et al. TUNEL: improvement and evaluation of the method for in situ apoptotic cell identification. Biochemica 1997; 2: 12-7.
15. Jacobs JJL, Lehé C, Cammans KDA, Yoneda K, Das PK, Elliott GR. An automatic method for the quantification of immunostained human Langerhans cells. J Immunol Meth 2001; 247: 73-82.
16. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen AL. Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol 1997; 181: 140-5.
17. cip1 cooperate in enforcing rapamycin-induced G1 arrest and determine the cellular response to rapamycin. Cancer Res 2001; 61: 3373-81.
18. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43-56.
19. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400.
20. cip1 degradation. J Biol Chem 2002; 277: 9684-9.
21. cip1 and is involved in the regulation of its nuclear localization. J Biol Chem 1999; 274: 24445-8.